Citations

Clear

6273 citation(s) found for "To, Andrew".

An magnetic resonance imaging–pathology correlation case report of cardiac sarcoidosis mimicking arrhythmogenic biventricular cardiomyopathy
Kim, B Michelle , Bois, Melanie C. , Munoz, Freddy Del‐Carpio , Rosenbaum, Andrew , Chang, Ian C , Del-Carpio Munoz, Freddy , Rosenbaum, Andrew N , Kim, B Michelle

Mayo Clinic

European Heart Journal - Case Reports | August 5, 2024 | Volume: 8 | Issue: 8 | Pages: No page available

10.1093/ehjcr/ytae395 | PMID 39156954 Get It

Abstract Background Cardiac sarcoidosis (CS) is a granulomatous disease that can manifest as conduction defects, ventricular arrhythmias, and heart failure. The diagnosis of CS is inherently difficult due to variable presentations; as such, endomyocardial biopsy is often required but lacks sensitivity due to patchy myocardial involvement. Moreover, the diagnostic criteria of CS and arrhythmogenic cardiomyopathy overlap, particularly in right-side dominant or biventricular presentations, which further complicates an already challenging differential diagnosis. Case summary A 53-year-old man with no prior chronic medical conditions presented with ventricular tachycardia (VT) and heart failure with reduced ejection fraction. He was found to have biventricular cardiomyopathy and late gadolinium enhancement on cardiac magnetic resonance imaging, resulting in an initial diagnosis of arrhythmogenic cardiomyopathy. Implantable cardioverter-defibrillator was placed, but he was readmitted for recurrent VT 2 months later. Despite an aggressive VT therapy (combination of antiarrhythmic drugs, epicardial and endocardial ablation, and stellate ganglion block), he continued with refractory VT and developed cardiogenic shock. Extra-corporeal membrane oxygenation was initiated as a bridge to heart transplantation. Pathology of the explanted heart revealed the underlying disease to be CS. Discussion Cardiac sarcoidosis can mimic arrhythmogenic biventricular cardiomyopathy and may be difficult to distinguish by the proposed diagnostic criteria. High clinical suspicion and thorough investigation are necessary for an earlier diagnosis and initiation of treatment.
Resection versus resection with ablation: Analysis from the colorectal liver operative metastasis international collaborative
Mainali, Bigyan B. , Valenzuela, Cristian D. , Moaven, Omeed , Piccolo, Nico R. Del, Corvera, Carlos U. , Wisneski, Andrew D. , Zarandi, Nima Pourhabibi , Dourado, Justin , Shen, Perry , Del Piccolo, Nico R, Shen, Perry , Moaven, Omeed , Stauffer, John , Cheung, Tan To , Cha, Charles , Russell, Gregory B.

Mayo Clinic

Journal of Surgical Oncology | August 5, 2024 | Volume: 130 | Issue: 3 | Pages: 516-522

10.1002/jso.27789 | PMID 39099202 Get It

AbstractBackgroundThermal ablation has recently become a key therapy for the treatment of colorectal liver metastasis (CLM). However, the role of ablation in combination with resection has not yet been firmly established. We hypothesize that in patients with CLM, those who undergo liver resection with ablation (RA) have similar outcomes compared with those who undergo liver resection only.MethodsWe reviewed a multicenter international database of 906 surgical procedures for CLM from 5 high volume hepatobiliary surgical units. Patients undergoing RA (n = 63) were matched based on the number of lesions and tumor size using a 1:1 balanced propensity score analysis with those having resection only (n = 63). Our primary outcomes were overall survival (OS) and disease‐free survival (DFS).ResultsThe mean age of our cohort was 58 ± 11 years, with 43% females. With a median follow‐up of 70.8 months, patients in the resection and RA group had a median OS of 45.1 and 54.8 months (p = 0.71), respectively. The median DFS was 22.7 and 14.2 months (p = 0.045), respectively. Using a multivariate Cox proportional hazards regression model, the treatment approach was not associated with OS (p = 0.94) or DFS (p = 0.059). A higher number of lesions is independently associated with worse DFS (hazard ratio: 1.12, p < 0.01). When there was disease recurrence, the region of recurrence was similar between the RA versus resection only groups (p = 0.27), but there was a shorter time to recurrence in the RA group (p = 0.002).ConclusionFor CLM, the treatment approach was not significantly associated with OS or DFS, while tumor biology likely played an important role. Prospective research on the quality and effectiveness of thermal ablation combined with hepatic resection is warranted.
Cardiovascular Toxicities of Immune Therapies for Cancer – A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
Tocchetti, Carlo G. , Farmakis, Dimitrios , Koop, Yvonne , Andrés, María Sol , Formisano, Luigi , Ciardiello, Fortunato, Emmerich, Max , Plummer, Chris , Gulati, Geeta , Ramalingam, Sivatharshini , Brezden‐Masley, Christine , Iakobishvili, Zaza , Bergler‐Klein, Jutta , Boer, Rudolf A. de , Rassaf, Tienush, Fradley, Michael G. , Moslehi, Javid J. , Yang, Eric H., Neilan, Tomas G. , Herrmann, Joerg , Mirabel, Mariana , Skouri, Hadi , Cohen‐Solal, Alain , Sverdlov, Aaron L. , Meer, Peter van der, Asteggiano, Riccardo , Ky, Bonnie , Seferović, Petar , Metra, Marco , Rosano, Giuseppe, Suter, Thomas, Tocchetti, Carlo Gabriele , López-Fernández, Teresa , de Boer, Rudolf A , Ky, Bonnie , Sverdlov, Aaron L , Metra, Marco , Couch, Liam Steven , Ciardiello, Fortunato , Pane, Fabrizio , Au, Lewis , Cardinale, Daniela , Thavendiranathan, Paaladinesh , Santoro, Ciro , Keramida, Kalliopi , Maack, Christoph , Lutgens, Esther , Rassaf, Tienush , Yang, Eric H., Keulenaer, Gilles W. De , Ameri, Pietro , Bax, Jeroen J. , Mbakwem, Amam , Hirsch, Emilio , Meer, Peter van der , Barac, Ana , Lenihan, Daniel , Dent, Susan , Coats, Andrew J.S. , López‐Fernández, Teresa , Lyon, Alexander R.

Mayo Clinic

European Journal of Heart Failure | August 1, 2024 | Volume: 26 | Issue: 10 | Pages: 2055-2076

10.1002/ejhf.3340 | PMID 39087551 Get It

ABSTRACT The advent of immunological therapies has revolutionized the treatment of solid and haematological cancers over the last decade. Licensed therapies which activate the immune system to target cancer cells can be broadly divided into two classes. The first class are antibodies that inhibit immune checkpoint signalling, known as immune checkpoint inhibitors (ICIs). The second class are cell-based immune therapies including chimeric antigen receptor T lymphocyte (CAR-T) cell therapies, natural killer (NK) cell therapies, and tumour infiltrating lymphocyte (TIL) therapies. The clinical efficacy of all these treatments generally outweighs the risks, but there is a high rate of immune-related adverse events (irAEs), which are often unpredictable in timing with clinical sequalae ranging from mild (e.g. rash) to severe or even fatal (e.g. myocarditis, cytokine release syndrome) and reversible to permanent (e.g. endocrinopathies).The mechanisms underpinning irAE pathology vary across different irAE complications and syndromes, reflecting the broad clinical phenotypes observed and the variability of different individual immune responses, and are poorly understood overall. Immune-related cardiovascular toxicities have emerged, and our understanding has evolved from focussing initially on rare but fatal ICI-related myocarditis with cardiogenic shock to more common complications including less severe ICI-related myocarditis, pericarditis, arrhythmias, including conduction system disease and heart block, non-inflammatory heart failure, takotsubo syndrome and coronary artery disease. In this scientific statement on the cardiovascular toxicities of immune therapies for cancer, we summarize the pathophysiology, epidemiology, diagnosis, and management of ICI, CAR-T, NK, and TIL therapies. We also highlight gaps in the literature and where future research should focus.
Editorial. Two novel models to optimize transitional care in spina bifida: the patient as provider and the congenital neurosurgeon in active collaboration
Bevans, Shannon, Swana, Hubert S., Pattisapu, Jogi V. , Hopson, Betsy , Harmon, Daniel, Blount, Jeffrey P. , Foy, Andrew , Clarke, Michelle J.

Mayo Clinic

Neurosurgical Focus | August 1, 2024 | Volume: 57 | Issue: 2 | Pages: E2

10.3171/2024.6.focus24387 | PMID 39088857 Get It

Predictors of Delayed Clinical Benefit Following Surgical Treatment for Low-grade Spondylolisthesis
Djurasovic, Mladen, Bisson, Erica F. , Chan, Andrew K. , Bydon, Mohamad , Mummaneni, Praveen V., Foley, Kevin T. , Shaffrey, Christopher I. , Potts, Eric A. , Shaffrey, Mark E., Coric, Domagoj , Knightly, John J. , Wang, Michael Y. , Fu, Kai-Ming, Slotkin, Jonathan R., Virk, Michael S., Chou, Dean , Haid, Regis W., Glassman, Steven D. , Carreon, Leah Y. , Mummaneni, Praveen V. , Park, Paul , Fu, Kai-Ming, Asher, Anthony L., Virk, Michael S.

Mayo Clinic

Spine | August 1, 2024 | Volume: 50 | Issue: 11 | Pages: E213-E218

10.1097/brs.0000000000005115 | PMID 39087454 Get It

Study Design. Retrospective review of prospectively collected data. Objective. The aim of this study was to investigate what factors predict delayed improvement after surgical treatment of low-grade spondylolisthesis. Summary of Background Data. Lumbar surgery leads to clinical improvement in the majority of patients with low-grade spondylolisthesis. Most patients improve rapidly after surgery, but some patients demonstrate a delayed clinical course. Methods. The Quality and Outcomes Database (QOD) was queried for grade 1 spondylolisthesis patients who underwent surgery who had patient-reported outcome measures (PROMs) collected at baseline, 3, 6, and 12 months, including back and leg pain Numeric Rating Scale (NRS), Oswestry Disability Index (ODI), and EuroQol-5D (EQ-5D). Patients were stratified as “early responders” reaching MCID at 3 months and maintaining improvement through 12 months and “delayed responders” not reaching MCID at 3 months but ultimately reaching MCID at 12 months. These two groups were compared with respect to factors which predicted delayed improvement. Results. Of 608 patients enrolled, 436 (72%) met inclusion criteria for this study. Overall, 317 patients (72.7%) reached MCID for ODI at 12 months following surgery. Of these patients, 249 (78.5%) exhibited a rapid clinical improvement trajectory and had achieved ODI MCID threshold by the 3-month postoperative follow-up. Sixty-eight patients (21.4%) showed a delayed trajectory, and had not achieved ODI MCID threshold at 3 months, but did ultimately reach MCID at 12-month follow-up. Factors associated with delayed improvement included impaired preoperative ambulatory status, better baseline back and leg pain scores, and worse 3-month leg pain scores ( P <0.01). Conclusions. The majority of patients undergoing surgery for low-grade spondylolisthesis reach ODI MCID threshold rapidly, within the first 3 months after surgery. Factors associated with a delayed clinical course include impaired preoperative ambulation status, relatively better preoperative back and leg pain, and persistent leg pain at 3 months.
Fat-Free Mass Index in Sport: Normative Profiles and Applications for Collegiate Athletes
Jones, Margaret T. , Fields, Jennifer B. , Magee, Meghan K., Luedke, Joel, Jagim, Andrew R. , Harty, Patrick S. , Smith‐Ryan, Abbie E. , Kerksick, Chad M.

Mayo Clinic

Journal of Strength & Conditioning Research | July 29, 2024 | Volume: 38 | Issue: 9 | Pages: 1687-1693

10.1519/jsc.0000000000004864 | PMID 39074219 Get It

Abstract Jagim, AR, Harty, PS, Jones, MT, Fields, JB, Magee, M, Smith-Ryan, AE, Luedke, J, and Kerksick, CM. Fat-free mass index in sport: normative profiles and applications for collegiate athletes. J Strength Cond Res 38(9): 1687–1693, 2024—Recent concerns have been raised regarding the ethical considerations of conducting body composition assessments in sports. Specific apprehensions pertain to the inappropriate use of percent body fat and the limited application of the results to performance and recovery. Fat-free mass index (FFMI), a height-adjusted assessment of FFM, can serve as an alternative body composition metric to focus on in sports. Fat-free mass index provides valuable context regarding an optimal amount of FFM, accounting for skeletal frame and height while helping to qualify an athlete's FFM as low, moderate, or high. This review posits that shifting the focus of body composition measures to FFM can support more ideal targets across athletic seasons, careers, and the return to play after injury. In addition, a FFM focus may help change the perception of body composition assessment and how athletes perceive their current body because of the increased focus on the FFM compartment and the goal of maximizing tissue accrual, rather than focusing on fat loss. Fat-free mass index is calculated by dividing FFM (kg) by height (m 2 ) and can serve to normalize FFM, relative to height, and enable comparisons across athletes, sport types, and sex. Previous research has identified differences in FFMI across sex and among sport categories. Still, there is a need for more published data to develop optimal ranges for FFMI across sex, sports, and positions. As more data become available, FFMI has the potential to provide normative guidelines for optimal FFM development, performance, and injury risk reduction. The purpose of the current review was to summarize FFMI values across collegiate sport categories and competitive status to provide normative profiles, according to sex and sport type.
Impact of acute kidney injury response on survival and liver transplant rates in hospitalized patients with cirrhosis awaiting liver transplantation: Results from the HRS-HARMONY consortium
Ouyang, Tianqi , Belcher, Justin M. , Patidar, Kavish R. , Cullaro, Giuseppe , Wadei, Hani M. , Regner, Kevin R. , Dageforde, Leigh Anne , Przybyszewski, Eric M. , Duarte‐Rojo, Andrés , Wahid, Nabeel , Hillien, Shelsea A. St., Robinson, Jevon E., Allegretti, Andrew S. , Robinson, Jevon E. , Wadei, Hani M , Duarte-Rojo, Andres , Patidar, Kavish R , Cullaro, Giuseppe , Li, Xing , Asrani, Sumeet K. , Simonetto, Douglas A. , Wilechansky, Robert M. , Sharma, Pratima , Ufere, Nneka N , Orman, Eric S. , Chung, Raymond T.

Mayo Clinic

Liver Transplantation | July 29, 2024 | Volume: 30 | Issue: 11 | Pages: 1106-1115

10.1097/lvt.0000000000000445 | PMID 39073567 Get It

Acute kidney injury (AKI) frequently complicates the course of hospitalized patients with cirrhosis and negatively affects their prognosis. How AKI response influences the timing of liver transplantation (LT) remains unclear. We sought to assess the impact of AKI response to treatment on survival and LT rates in patients with cirrhosis awaiting LT. This was a retrospective multicenter study of cirrhosis patients waitlisted for LT and hospitalized with AKI in 2019. The exposure was AKI response versus no response during hospitalization. Outcomes were 90-day overall and transplant-free survival, and rates of LT with time to transplant. We adjusted for age, sex, race, cirrhosis etiology, site, and Model for End-Stage Liver Disease-Sodium (MELD-Na) score. Among the 317 patients in this study, 170 had an AKI response (53.6%), and 147 had no response (46.4%). Compared to nonresponders, responders had better 90-day overall survival (89.4% vs. 76.2%, adjusted subhazard ratio for mortality 0.34, p=0.001), and transplant-free survival (63.5% vs. 25.2%, aHR for probability of death or transplant 0.35, p<0.001). The LT rate was lower in responders (45.9% vs. 61.2%, adjusted subhazard ratio 0.55, p=0.005); 79% of transplants in responders occurred after discharge, at a median of 103 days, while 62% of transplants in nonresponders occurred during hospitalization, with the remainder occurring postdischarge at a median of 58 days. In patients with cirrhosis waitlisted for LT who are hospitalized with AKI, AKI response to therapy is associated with improved 90-day survival, despite a reduced LT rate and longer time to LT.
Validation of Bioelectrical Impedance Devices for the Determination of Body Fat Percentage in Firefighters
Luedke, Joel, Erickson, Jacob L. , Fields, Jennifer B. , Jones, Margaret T. , Jagim, Andrew R.

Mayo Clinic

Journal of Strength & Conditioning Research | July 29, 2024 | Volume: 38 | Issue: 8 | Pages: e448-e453

10.1519/jsc.0000000000004809 | PMID 39072665 Get It

Abstract Jagim, AR, Luedke, J, Erickson, JL, Fields, JB, and Jones, MT. Validation of bioelectrical impedance devices for the determination of body fat percentage in firefighters. J Strength Cond Res 38(8): e448–e453, 2024—To cross-validate bioelectrical impedance devices for the determination of body fat percentage (BF%) in firefighters. Twenty-eight structural firefighters were evaluated (female, n = 2; male, n = 26 [mean ± SD ] age: 38.2 ± 8.3 years; height: 180.2 ± 7.5 cm; body mass: 86.7 ± 20.8 kg; body mass index: 25.8 ± 7.8 kg·m −2 ) using multifrequency bioelectrical impedance analysis (MFBIA) hand-to-foot device, and single-frequency BIA foot scale (F2FBIA), and a single-frequency handheld BIA device (HHBIA). Dual X-ray absorptiometry served as the criterion. Validity metrics were examined to establish each method's performance. Body fat % values produced by MFBIA ( r = 0.913), F2FBIA ( r = 0.695), and HHBIA ( r = 0.876) were strongly associated ( p < 0.001) with criterion BF% measures. However, MFBIA, F2FBIA, and HHBIA all significantly ( p < 0.001) underestimated BF% when compared with the criterion measure. Constant error ranged between 4.0 and 5.5% across all BIA devices. Despite strong associations between the BIA devices included in the current study and the criterion measure, all BIA devices underestimated BF%, which resulted in an overestimation of fat-free mass. In addition, proportional bias was observed in which BF% was overestimated at lower values and underestimated at higher values.
Seasonal Changes in Match Demands and Workload Distribution in Collegiate Soccer Across Two Seasons
Floersch, Sean, Vidden, Chad, Askow, Andrew T. , Jones, Margaret T. , Fields, Jennifer B. , Askow, Andrew T , Jagim, Andrew R.

Mayo Clinic

Journal of Strength & Conditioning Research | July 29, 2024 | Volume: 38 | Issue: 8 | Pages: 1440-1446

10.1519/jsc.0000000000004802 | PMID 39072657 Get It

Abstract Floersch, S, Vidden, C, Askow, AT, Jones, MT, Fields, JB, and Jagim, AR. Seasonal changes in match demands and workload distribution in collegiate soccer across two seasons. J Strength Cond Res 38(8): 1440–1446, 2024—The purpose of this study was to examine seasonal changes in match demands in a collegiate women's soccer team. Forty-eight NCAA Division III women soccer athletes (age: 19.5 ± 1.2 years; height: 1.67 ± 0.05 m; body mass: 64.8 ± 7.4 kg; fat-free mass: 50.0 ± 4.5 kg; body fat %: 22.6 ± 6.0) were equipped with wearable global positioning systems with inertial sensors and heart rate (HR) monitors during matches throughout the 2019 ( n = 22) and 2021 seasons ( n = 26). Players were classified by position: flank player (FP; n = 28), center midfielder (CM; n = 11), and center back fielder (CB; n = 9) and as starters (S, n = 17) or reserves (R, n = 31). Variables included HR, training load, total distance, high-speed distance, distance per minute, and weighted distance. Differences in match and practice session demands were analyzed using linear mixed-effects models with season (2 levels; 2019 and 2021) as a fixed factor, with alpha set to p = 0.05. Data across all matches and training sessions were collapsed and presented as mean ± SD for descriptive purposes and then grouped by session type (i.e., match or training) and position. Athletes traveled more distance at high speeds during match play in the 2021 season compared with 2019 (mean difference, 95% confidence intervals [CI]) (200, 95% CI: 104, 304 km; p < 0.05) but had a lower training load in 2021 compared with 2019 (−50, 95% CI: −63, −36; p < 0.05) during match play. For training sessions, mean HR (4, 95% CI: 2, 5 bpm), total distance (0.5, 95% CI: 0.4, 0.7), distance per minute (5.6, 95% CI: 4.5, 6.7 m·min −1 ), high-speed distance (43, 95% CI: 43, 18, 67 m), high accelerations (8.6, 95% CI: 5.4, 11.8 n ), and high accelerations per minute (0.1, 95% CI: 0.1, 0.1 n ·min −1 ) were all higher in 2021 compared with 2019 ( p < 0.05). As a team, several differences in measures of external workload were found between seasons in both session types (training and matches). Variations in positional demands of match play appear to fluctuate by year.